Retifanlimab with carboplatin and paclitaxel for locally recurrent or metastatic squamous cell carcinoma of the anal canal (POD1UM-303/InterAACT-2): a global, phase 3 randomised controlled trial Lancet. 2025;405(10495):2144-2152 https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40517007
The usefulness of serum leucine-rich alpha-2 glycoprotein as a novel biomarker in monitoring inflammatory bowel disease: a systematic review and meta-analysis European Journal of Gastroenterology and Hepatology. 2025;37(8):891-904 https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39976047
Aseptic Abscess of the Gallbladder Mimicking Gallbladder Carcinoma after Surgery for Ulcerative Colitis Internal Medicine. 2025;64(13):1984-1992
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39631865
Biologics for eosinophilic oesophagitis: a systematic review and meta-analysis Annals of Medicine. 2025;57(1):2445192
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39707826
Changes in Hepatic Density Due to Oral Amiodarone-induced Liver injury Shown by Computed Tomography Internal Medicine. 2025;64(12):1828-1833
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39566986
Clinical Validation of a Circulating Tumor DNA-Based Blood Test to Screen for Colorectal Cancer JAMA. 2025;334(1):56-63
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40455622
Clinicopathological Study on Endothelial Injury in Severe Glomerular Microangiopathy Induced by Ramucirumab Internal Medicine. 2025;64(13):2024-2030
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40603057
Crohn’s Disease with Granulomatous Interstitial Nephritis as an Extraintestinal Complication from the Time of the Diagnosis Internal Medicine. 2025;64(13):1979-1983
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39694489
Efficacy of the Bridge Dry Swallowing Exercise for Refractory Gastroesophageal Reflux Disease Internal Medicine. 2025;64(12):1799-1807
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39662917
Efruxifermin in Compensated Liver Cirrhosis Caused by MASH New England Journal of Medicine. 2025;392(24):2413-2424
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40341827
Encorafenib, Cetuximab, and mFOLFOX6 in BRAF-Mutated Colorectal Cancer New England Journal of Medicine. 2025;392(24):2425-2437
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40444708
Esophageal Dysfunction in Immune Checkpoint Inhibitor-related Myositis Internal Medicine. 2025;64(13):2068-2072
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39721696
Impact of Prehabilitation in Major Gastrointestinal Oncological Surgery: a Systematic Review Journal of Gastrointestinal Cancer. 2025;56(1):133
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40500487
Increased risk of peptic ulcer following periodontitis: a systematic review and meta-analysis European Journal of Medical Research. 2025;30(1):584
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40619409
Neuroendocrine carcinoma of esophagus: systematic review and meta-analysis of case series BMC Gastroenterology. 2025;25(1):462
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40597692
Nonoperative Management of Mismatch Repair-Deficient Tumors New England Journal of Medicine. 2025;392(23):2297-2308
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40293177
Olmesartan-associated Gastritis Observed Over Time Internal Medicine. 2025;64(12):1843-1848
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39603626
Predictors of Atherosclerotic Cardiovascular Disease Events in Patients with Metabolic Dysfunction-associated Steatotic Liver Disease Internal Medicine. 2025;64(12):1791-1798
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39566988
Prevalence of low-level viremia in the treatment of chronic hepatitis B in China: a systematic review and meta-analysis BMJ Open. 2025;15(6):e088756
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40578863
Pseudogenes as Potential Diagnostic, Prognostic and Therapeutic Biomarkers in Colorectal Cancer: A Systematic Review Cancer Rep (Hoboken). 2025;8(6):e70263
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40556338
Radiofrequency Ablation Technology in Liver Malignancies: A Systematic Review of Economic Evaluations Journal of Gastrointestinal Cancer. 2025;56(1):135
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40504321
Retifanlimab with carboplatin and paclitaxel for locally recurrent or metastatic squamous cell carcinoma of the anal canal (POD1UM-303/InterAACT-2): a global, phase 3 randomised controlled trial Lancet. 2025;405(10495):2144-2152
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40517007
Risk factors for hepatocellular carcinoma: an umbrella review of systematic review and meta-analysis Annals of Medicine. 2025;57(1):2455539
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39834076
Structured Exercise after Adjuvant Chemotherapy for Colon Cancer New England Journal of Medicine. 2025;393(1):13-25
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40450658
Surgical Treatment of Hepatocellular Carcinoma Arising from Fontan-associated Liver Disease: A Report of Three Cases Internal Medicine. 2025;64(12):1834-1842
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39603624
Things We Do for No Reason™: Avoiding naltrexone for alcohol use disorder in liver disease Journal of Hospital Medicine. 2025;20(7):768-771
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39655573
The usefulness of serum leucine-rich alpha-2 glycoprotein as a novel biomarker in monitoring inflammatory bowel disease: a systematic review and meta-analysis European Journal of Gastroenterology and Hepatology. 2025;37(8):891-904
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39976047